Respir Med Case Rep. 2020 Aug 28:101205. doi: 10.1016/j.rmcr.2020.101205. Online ahead of print.
Evidence supporting the use of dexamethasone in severe COVID-19 patients is emerging. In this case series, we share our experience in using dexamethasone in five COVID-19 infected patients with acute respiratory distress syndrome.
PMID:32874905 | PMC:PMC7452843 | DOI:10.1016/j.rmcr.2020.101205